Fact CheckerSign in

NCT05690308Completed

Visual Perturbation Training to Reduce Fall Risk in People with Parkinson's Disease

A Novel Training Method to Reduce Fall Risk in People with Parkinson's Disease: the Role of the Balance Organ

Source: ClinicalTrials.gov · Last updated 19 Sept 2024

Brief summary (registry, in English)

Falls during walking are common in people with Parkinson's Disease (PD). Fall risk can be attributed in part to the loss of automaticity in walking and an increased reliance on sensory cues, such as the input from the balance organ. In this project the investigators want to assess the effectiveness of rehabilitation training aiming to improve this vestibular input. The effects of a visual perturbation training in a virtual reality environment will be compared to conventional treadmill training.

Status (registry)
Completed
Study type
Interventional
Enrollment
35 (actual)
First submitted
1 Sept 2022
Start date
20 Dec 2022
Primary completion date
30 Mar 2024
Lead sponsor
University Hospital, Ghent
NCT number
NCT05690308

What you commit to

  • Study type: Interventional
  • Participants enrolled: 35
  • From 20 Dec 2022 to the primary completion date, 30 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Non-idiopathic Parkinson's disease
  • Illness other than Parkinson's disease (flu, Covid-19) or disabilities that may affect gait or equilibrium

Other

  • Strong variation in expressed symptoms
  • Inability to walk unassisted for 20 minutes
  • Underwent a medical procedure to treat Parkinson symptoms (e.g. duodopa pump, deep brain stimulator)
  • Cognitive disability (score \< 21 on the Montreal Cognitive Assessment)
  • Clogged ear(s)
  • Regular fainting episodes
  • Weight over 120 kg
  • Participation in other clinical studies

Who the study is looking for

  • Idiopathic Parkinson's disease
  • Aged between 50-65 years
  • Bilateral symptoms
  • Able to walk unassisted for 20 minutes (Hoehn \& Yahr stage II-III)
  • Stable medication dosage (if any)
  • No cognitive disablity

Age in the registry: 50 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UZ Gent
Coordinator of this site? Confirm its status
GhentBelgiumUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.